Kevin Patrick Danahy

Chief Commercial Officer, Pulse Biosciences, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$2.9M

Companies

Latest trade

Feb 18, 2026

Companies

Pulse Biosciences, Inc.Chief Commercial Officer −$3.0M

Trades

PLSE Sold 5,000 shares at $23.64 · planned $0.1M Feb 18

PLSE Sold 20,000 shares at $23.63 · planned $0.5M Feb 17

PLSE Sold 20,000 shares at $23.53 · planned $0.5M Feb 13

PLSE Sold 20,000 shares at $23.37 · planned $0.5M Feb 12

PLSE Sold 20,000 shares at $25.20 · planned $0.5M Feb 11

PLSE Sold 20,000 shares at $23.52 · planned $0.5M Feb 10

PLSE Sold 20,000 shares at $21.45 · planned $0.4M Feb 9

PLSE Sold 4,600 shares at $18.53 · planned $0.1M Oct 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.